A detailed history of Two Sigma Investments, LP transactions in Senti Biosciences, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 69,751 shares of SNTI stock, worth $152,754. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,751
Previous 93,621 25.5%
Holding current value
$152,754
Previous $35,000 45.71%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.24 - $0.4 $5,728 - $9,548
-23,870 Reduced 25.5%
69,751 $19,000
Q1 2024

May 15, 2024

BUY
$0.36 - $0.66 $23,392 - $42,885
64,978 Added 226.85%
93,621 $35,000
Q4 2023

Feb 14, 2024

BUY
$0.28 - $0.68 $8,020 - $19,477
28,643 New
28,643 $18,000

Others Institutions Holding SNTI

About Senti Biosciences, Inc.


  • Ticker SNTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,757,100
  • Market Cap $95.8M
  • Description
  • Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...
More about SNTI
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.